Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery

Neuromuscular Block, Residual Clinical Trial

Official title:
Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery: Comparison of Neostigmine and Sugammadex

Status Completed

Clinical Trial Summary

Compare the reversal effect of neostigmine and sugammadex using quantitative neuromuscular monitoring

Clinical Trial Description

At the end of surgery, decide the dosage of reversal referring to quantitative neuromuscular monitoring value (TOF). After the administration of reversal, the anesthesiologist who are going to manage the participant should not check the quantitative neuromuscular monitoring and determine the timing of extubation only with his (or her) judgement. After entering post-anaesthesia care unit (PACU) measure the TOF value and check the incidence of TOF ratio > 0.9 between the neostigmine group and sugammadex group. ;

Study Design

Related Conditions & MeSH terms

Delayed Emergence from Anesthesia
Neuromuscular Block, Residual

Clinical Trial Details

NCT number	NCT03292965
Study type	Interventional
Source	Seoul National University Bundang Hospital
Contact
Status	Completed
Phase	N/A
Start date	September 28, 2017
Completion date	November 29, 2017

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05053594` - Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children	Phase 4
Completed	`NCT03831815` - Evaluation of Residual Neuromuscular Blockade and of Late Recurarization in the Post Anesthesia Care Unit in Patients Undergoing Videolaparoscopic Cholecystectomy
Recruiting	`NCT05724550` - Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children	N/A